Promax Power provides engineering, procurement, and construction (EPC) services for power infrastructure, including transmission lines, substations, and solar energy projects, primarily for government and industrial clients.
The company operates in a highly competitive, tender-based EPC industry with low barriers to entry and thin net margins (2.0%). While management claims expertise in difficult terrains, the low average ROCE (7.4%) suggests a lack of durable competitive advantage or pricing power.
Capital has been deployed toward expanding the order book and investing in associates like EV charging and carbon advisory. However, the negative cash conversion and reliance on frequent equity dilution and unsecured promoter loans to fund working capital indicate a strained capital structure.
The company's collapse was driven by a classic working capital trap where rapid revenue growth masked a fundamental inability to collect cash. As negative cash conversion persisted, the interest coverage ratio—already a precarious 1.44—crumbled under the weight of rising debt and promoter loans. The business eventually choked on its own growth, as the thin 2% margins provided no buffer for project delays or cost overruns, leading to a liquidity crisis that forced massive, value-destroying equity dilutions just to keep the lights on.
RichFakir rates Promax Power Ltd's business quality as poor — 22/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Promax Power Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Promax Power Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Promax Power Ltd's fair value is about ₹7 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →